OrbusNeich Medical Group Holdings Limited (stock code: 06929) published its monthly return for the period ended 31 October 2025. According to the announcement, the authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.0005, totaling USD 600,000. The number of issued shares likewise stayed at 827,968,337, with no treasury shares reported.

Under the Pre-IPO Share Option Scheme, 24,000 share options lapsed, reducing the total outstanding options to 7,748,500 by the end of the month. The Post-IPO Share Option Scheme also saw a lapse of 75,000 share options, bringing the total outstanding options for that scheme to 4,494,500. There were no new shares issued from either scheme, and no treasury shares were transferred during the reporting period. The company did not raise funds through the exercise of share options in October.